Rabbit Anti-Human IgG H&L (ab6715)
Key features and details
- Rabbit Anti-Human IgG H&L
- Host species: Rabbit
- Suitable for: IP, Immunodiffusion, Conjugation, ICC/IF, ELISA, WB, IHC-P, IHC-Fr
Related conjugates and formulations
Overview
-
Product name
Rabbit Anti-Human IgG H&L
See all IgG secondary antibodies -
Host species
Rabbit -
Target species
Human -
Tested applications
Suitable for: IP, Immunodiffusion, Conjugation, ICC/IF, ELISA, WB, IHC-P, IHC-Frmore details -
Immunogen
Human IgG whole molecule
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.01% Sodium azide
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride -
Concentration information loading... -
Purity
Affinity purified -
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
Clonality
Polyclonal -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab6715 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IP |
Use at an assay dependent concentration.
|
|
| Immunodiffusion |
Use at an assay dependent concentration.
|
|
| Conjugation |
Use at an assay dependent concentration.
|
|
| ICC/IF |
1/2000 - 1/10000.
|
|
| ELISA |
1/1e+006.
|
|
| WB |
1/10000 - 1/50000.
|
|
| IHC-P |
Use at an assay dependent concentration.
|
|
| IHC-Fr |
Use at an assay dependent concentration.
|
| Notes |
|---|
|
IP
Use at an assay dependent concentration. |
|
Immunodiffusion
Use at an assay dependent concentration. |
|
Conjugation
Use at an assay dependent concentration. |
|
ICC/IF
1/2000 - 1/10000. |
|
ELISA
1/1e+006. |
|
WB
1/10000 - 1/50000. |
|
IHC-P
Use at an assay dependent concentration. |
|
IHC-Fr
Use at an assay dependent concentration. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (6)
ab6715 has been referenced in 6 publications.
- Chen Y et al. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis. Clin Transl Oncol N/A:N/A (2021). PubMed: 33934291
- Cai F et al. Upregulation of long non-coding RNA SNHG16 promotes diabetes-related RMEC dysfunction via activating NF-?B and PI3K/AKT pathways. Mol Ther Nucleic Acids 24:512-527 (2021). PubMed: 33898104
- Lai W et al. HJURP promotes proliferation in prostate cancer cells through increasing CDKN1A degradation via the GSK3ß/JNK signaling pathway. Cell Death Dis 12:583 (2021). PubMed: 34099634
- Gao L et al. Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells. Onco Targets Ther 13:2725-2738 (2020). PubMed: 32280246
- Li Y et al. Long non-coding RNA LINC00641 suppresses non-small-cell lung cancer by sponging miR-424-5p to upregulate PLSCR4. Cancer Biomark 26:79-91 (2019). PubMed: 31322545
- Wang ZL et al. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer. Biosci Rep 39:N/A (2019). PubMed: 31693087